Published in Arch Dis Child on February 01, 1983
Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord (2003) 1.33
Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child (1994) 0.93
Endocrine function in thalassemia intermedia. Int J Biomed Sci (2006) 0.89
Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload. Postgrad Med J (1985) 0.83
Thyroid function in major thalassemia patients: Is it related to height and chelation therapy? Caspian J Intern Med (2011) 0.78
Impact of genotype on endocrinal complications in β-thalassemia patients. Biomed Rep (2016) 0.75
Total management of thalassaemia major. Arch Dis Child (1977) 1.82
Prevention of iron loading in transfusion-dependent thalassaemia. Lancet (1978) 1.47
Scurvy and altered iron stores in thalassemia major. N Engl J Med (1981) 1.45
High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease. J Clin Endocrinol Metab (1975) 1.41
Endocrine function in thalassemia major. Ann N Y Acad Sci (1974) 1.40
Hormonal changes in thalassaemia major. Arch Dis Child (1976) 1.36
Impaired peripheral conversion of thyroxine to triiodothyronine,. Annu Rev Med (1977) 1.28
Binding of serum ferritin to concanavalin A: patients with homozygous beta thalassaemia and transfusional iron overload. Br J Haematol (1980) 1.23
Endocrine abnormalities in thalassemia major. Am J Dis Child (1979) 1.18
Endocrinopathy in thalassaemia major. Arch Dis Child (1976) 1.10
Circulating thyroid hormone levels in children. Arch Dis Child (1977) 1.05
Gonadotrophin, thyrotrophin and prolactin reserve in beta thalassaemia. Clin Endocrinol (Oxf) (1978) 1.04
Reduced active thyroid hormone levels in acute illness. Lancet (1976) 1.02
Endocrine assessment of hypogonadism in patients affected by thalassaemia major. Ric Clin Lab (1981) 1.00
Serum ferritin, liver iron stores, and liver histology in children with thalassaemia. Arch Dis Child (1980) 0.98
Endocrine evaluation in thalassemia major. Ann N Y Acad Sci (1974) 0.97
Gonadotropin insufficiency in patients with thalassemia major. J Clin Endocrinol Metab (1979) 0.90
Triiodothyronine and thyroid-stimulating hormone in protein-calorie malnutrition in infants. Lancet (1975) 0.86
Thyroid function in thalassaemia major. Arch Dis Child (1980) 0.81
Metabolic clearance and production rates of 3,3',5-triiodothyronine in hyperthyroid, euthyroid, and hypothyroid subjects. J Clin Endocrinol Metab (1978) 0.81
Growth retardation, skeletal maturation and thyroid function in children with homozygous beta-thalassaemia. Clin Endocrinol (Oxf) (1978) 0.79
Pathophysiology of thalassemia. Ann N Y Acad Sci (1980) 0.79
A 3,3',5'-triiodothyronine (reverse T3) radioimmunoassay. Ric Clin Lab (1978) 0.78
[The integration of nuclear medicine methods into cardiology: an operative proposal]. G Ital Cardiol (1992) 2.68
Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects. Cardiology (1989) 1.42
Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy. Acta Anaesthesiol Scand (2007) 1.42
Hepatitis C virus antibodies in a long-term follow-up of beta-thalassaemic children with acute and chronic non-A non-B hepatitis. Eur J Pediatr (1992) 1.40
Gonadal function after allogenic bone marrow transplantation for thalassaemia. Arch Dis Child (1991) 1.39
Safety profile of the oral iron chelator deferiprone: a multicentre study. Br J Haematol (2000) 1.32
Did malaria select for primary adult lactase deficiency? Gut (1994) 1.19
Growth and sexual maturation in thalassemia major. J Pediatr (1985) 1.16
Screening for beta-thalassaemia heterozygotes. Lancet (1980) 1.15
Reproductive compensation in families segregating for Cooley's anaemia in Ferrara. Ann Hum Genet (1978) 1.14
Assessment of prospective genetic counseling in the Ferrara area. Am J Med Genet (1980) 1.12
Hypoparathyroidism in beta-thalassemia major. Clinical and laboratory observations in 24 patients. Acta Haematol (1992) 1.09
Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child (1984) 1.03
Endocrine abnormalities in thalassemia. Ann N Y Acad Sci (1990) 1.02
Endocrine assessment of hypogonadism in patients affected by thalassaemia major. Ric Clin Lab (1981) 1.00
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer. Br J Cancer (2011) 1.00
Appearance of beta globin synthesis in erythroid cells of Ferrara beta -o-thalassaemic patients following blood transfusion. Nature (1975) 1.00
Induction of spermatogenesis in thalassaemia. Fertil Steril (1988) 0.97
A two-locus model for non-syndromic congenital dysplasia of the hip (CDH). Ann Hum Genet (2000) 0.96
Growth and development in thalassaemia major patients with severe bone lesions due to desferrioxamine. Eur J Pediatr (1996) 0.96
Screening for developmental dysplasia of the hip: from theory to practice. Collaborative Group DDH Project. Pediatrics (1997) 0.94
Genetic counselling in beta thalassemia in Ferrara. J Genet Hum (1980) 0.92
Right ventricular failure: physiology and assessment. Minerva Anestesiol (2005) 0.90
Transitory depression of immune function following Mycoplasma pneumoniae infection in children. Pediatr Res (1981) 0.90
Raised IgE levels in beta-thalassaemia: correlation with splenectomy and hepatitis B virus infection. Clin Exp Immunol (1984) 0.89
A study of nine polymorphic systems in the population of the Po Delta. Am J Phys Anthropol (1976) 0.89
Gonadal function in patients with beta thalassaemia major. J Clin Pathol (1988) 0.89
Low red blood cell glutathione reductase and pyridoxine phosphate oxidase activities not related to dietary riboflavin: selection by malaria? Am J Clin Nutr (1993) 0.88
Haemoglobin levels and blood requirement in thalassaemia. Arch Dis Child (1982) 0.88
Circadian rhythms of atrial natriuretic peptide, renin, aldosterone, cortisol, blood pressure and heart rate in normal and hypertensive subjects. J Hypertens (1990) 0.87
Psychosocial integration of adolescents and young adults with thalassemia major. Ann N Y Acad Sci (1998) 0.87
The menopausal transition: a dynamic approach to the pathogenesis of neurovegetative complaints. Eur J Obstet Gynecol Reprod Biol (1994) 0.87
Peripheral quantitative Computed Tomography (PQCT) in the evaluation of bone geometry, biomechanics and mineral density in postmenopausal women. Radiol Med (2002) 0.86
McCune-Albright syndrome: a longitudinal clinical study of 32 patients. J Pediatr Endocrinol Metab (2000) 0.85
Serum CA 125 in ovarian pathology and its variation in ovarian carcinoma after integrated therapy. Gynecol Obstet Invest (1986) 0.85
Hypothalamic-pituitary-gonadal axis in thalassemic patients with secondary amenorrhea. Obstet Gynecol (1988) 0.84
[Pericentric inversion of chromosome 4 : inv (4) (p13, q35) and trisomy of the short branch of chromosome 4 due to recombination aneusomy]. Ann Genet (1974) 0.84
Short-term effect of oophorectomy on lipoprotein metabolism. Gynecol Obstet Invest (1984) 0.83
Genetic and other influences on red-cell flavin enzymes, pyridoxine phosphate oxidase and glutathione reductase in families with beta-thalassaemia. Eur J Haematol (1989) 0.83
Alpha and beta cell evaluation in patients with thalassaemia intermedia and iron overload. Postgrad Med J (1985) 0.83
Early iron overload in beta-thalassaemia major: when to start chelation therapy? Arch Dis Child (1982) 0.83
Biological performance in beta-thal heterozygotes and normals: results of a longitudinal comparison in a former malarial environment. Ann Hum Genet (1987) 0.83
Correlation of MAST chemiluminescent assay (CLA) with RAST and skin prick tests for diagnosis of inhalant allergic disease. Ann Allergy (1989) 0.83
[Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology]. Radiol Med (1988) 0.82
Effect of different treatment regimes on linear growth and final height in beta-thalassaemia major. Clin Endocrinol (Oxf) (1994) 0.82
Comparative evaluation of RAST and MAST-CLA for six allergens for the diagnosis of inhalant allergic disease in 232 patients. Clin Exp Allergy (1992) 0.82
Changes in superoxide anion production in neutrophils from multitransfused beta-thalassemia patients: correlation with ferritin levels and liver damage. Acta Haematol (1984) 0.81
Reproductive behaviour of families segregating for Cooley's anaemia before and after the availability of prenatal diagnosis. J Med Genet (1991) 0.81
[Use of technetium in thyroid scintigraphy]. Minerva Radiol (1969) 0.80
Organization of alpha-globin genes and mRNA translation in subjects carrying haemoglobin Hasharon (alpha 47 Asp replaced by His) from the Ferrara Region (Northern Italy). Eur J Biochem (1980) 0.80
Haplotypes of thalassaemic families from the Po river delta: importance for prenatal diagnosis of beta-thalassaemia. Eur J Haematol (1988) 0.80
Beta-thalassemia in the Po Delta: selection, geography, and population structure. Am J Hum Genet (1984) 0.80
Glutathione reductase activity and its relationship to pyridoxine phosphate activity in G6PD deficiency. Eur J Haematol (1987) 0.80
Induction of humoral autoimmune response to rat male accessory glands. Medicina (B Aires) (1981) 0.80
Red-cell GSH regeneration and glutathione reductase activity in G6PD variants in the Ferrara area. Br J Haematol (1987) 0.80
Influence of estrogens on serum free fatty acid levels in women. J Clin Endocrinol Metab (1990) 0.80
Ferrara beta 0 thalassaemia caused by the beta 39 nonsense mutation. Nature (1984) 0.80
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension. J Hypertens (1992) 0.80
Reproductive behavior of thalassemic couples segregating for Cooley anemia. Am J Med Genet (1991) 0.80
Low-dose intravenous calcitriol treatment of secondary hyperparathyroidism in hemodialysis patients. Italian Group for the Study of Intravenous Calcitriol. Kidney Int (1992) 0.80
Hormonal sensitivity of adenylate cyclase from human endometrium: modulation by estradiol. J Steroid Biochem (1985) 0.79
Pharmacokinetics of sex steroids in patients with beta thalassaemia major. J Clin Pathol (1993) 0.79
Hereditary pyruvate kinase deficiency: role of the abnormal enzyme in red cell pathophysiology. Br J Haematol (1978) 0.79
Decrease of alpha-Hasharon globin in beta-thalassaemia. Br J Haematol (1978) 0.79
2006 GEP-ISFG collaborative exercise on mtDNA: reflections about interpretation, artefacts, and DNA mixtures. Forensic Sci Int Genet (2007) 0.79
Social integration of the older thalassaemic patient. Arch Dis Child (1990) 0.79
Is the flavin-deficient red blood cell common in Maremma, Italy, an important defense against malaria in this area? Am J Hum Genet (1994) 0.79
HLA class I diversity in Kolla Amerindians. Hum Immunol (2001) 0.79
Clinical experience using the Androderm testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major. J Pediatr Endocrinol Metab (1998) 0.79
Beta-cell function assessed by plasma C-peptide evaluation in diabetic thalassaemic patients. Helv Paediatr Acta (1983) 0.78
Evaluation of the muscular relaxant effect of dexmedetomidine or medetomidine in cats. Vet Res Commun (2009) 0.78
Circadian profile of plasma calcitonin gene-related peptide in healthy man. J Clin Endocrinol Metab (1991) 0.78
An unusual adrenal metastasis secondary to Hürthle cell carcinoma of the thyroid. Clin Nucl Med (1996) 0.78
Deficiency of two red-cell flavin enzymes in a population in Sardinia: was glutathione reductase deficiency specifically selected for by malaria? Am J Hum Genet (1995) 0.78
Evaluation of a patient with a brain abscess caused by nocardia asteroides infection with Ga-67 and Tc-99m HMPAO leukocytes. Clin Nucl Med (1997) 0.78
Induction of ovulation in a thalassaemic patient. Acta Eur Fertil (1992) 0.78
A 3,3',5'-triiodothyronine (reverse T3) radioimmunoassay. Ric Clin Lab (1978) 0.78
Modification of number and of affinity of endometrial EGF receptors during the menstrual cycle. Eur J Obstet Gynecol Reprod Biol (1989) 0.77
Hypoparathyroidism in chronic alcohol intoxication: a preliminary report. Riv Eur Sci Med Farmacol (1993) 0.77
Evaluation of bone metabolic markers as indicators of osteopenia in climacteric women. Gynecol Obstet Invest (1992) 0.77
Efficacy of continuous venovenous haemofiltration (CVVH) in the treatment of severe phenformin-induced lactic acidosis. Nephrol Dial Transplant (1998) 0.77
Glucose tolerance and chelation therapy in patients with thalassaemia major. Haematologica (1983) 0.77
Skeletal changes in the "cri du chat" syndrome. Acta Genet Med Gemellol (Roma) (1973) 0.77
[Bone disease in multiple myeloma. A study of 237 cases]. Radiol Med (1992) 0.77